CRISPR Therapeutics AG (CRSP) FCF Margin Growth (5y) (2021 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) FCF Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91,314.00 |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 6.20 Mn |
| Mar 31, 2025 | 2.89 Mn |
| Dec 31, 2024 | -14,404.00 |
| Sep 30, 2024 | -1.79 Mn |
| Jun 30, 2024 | -650,004.00 |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Jun 30, 2023 | 217,020.00 |
| Mar 31, 2023 | 171,730.00 |
| Dec 31, 2022 | -199.19 Mn |
| Sep 30, 2022 | -11.75 Mn |
| Jun 30, 2022 | -9.55 Mn |
| Mar 31, 2022 | -1.50 Mn |
| Dec 31, 2021 | 16,589.00 |
| Sep 30, 2021 | -1.35 Mn |
| Jun 30, 2021 | 192,953.00 |